Resultados: 2

    Guideline No. 456: prenatal screening for fetal chromosomal anomalies

    J. obstet. gynaecol. Can; 46 (11), 2024
    To review the available prenatal aneuploidy screening options and to provide updated clinical guidelines for reproductive care providers. All pregnant persons receiving counselling and providing informed consent for prenatal screening. Implementation of the recommendations in this guideline should increa...

    Guideline No. 410: prevention, screening, diagnosis, and pregnancy Management for fetal neural tube defects

    J. obstet. gynaecol. Can; 43 (1), 2021
    This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population: Women who are pregnant or may become pregnant. Neural tube defect screening should be offered to all pregnant women. For preven...